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UNITED STATES COURT OF APPEALS 
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_____________ 
 
No. 13-4731 
_____________ 
 
IN RE: DIET DRUGS (PHENTERMINE/FENFLURAMINE/DEXFENFLURAMINE) 
PRODUCTS LIABILITY LITIGATION 
 
               Tonya R. Marler, 
                                           Appellant  
_______________ 
 
On Appeal from the United States District Court 
for the Eastern District of Pennsylvania 
 (D.C. No. 99-cv-20593; MDL Nos. 11-md-1203 and 16-md-1203) 
District Judge:  Hon. Harvey Bartle, III  
_______________ 
 
Submitted Under Third Circuit LAR 34.1(a) 
July 11, 2014 
 
Before:   RENDELL, CHAGARES, and JORDAN, Circuit Judges. 
 
(Filed: July 14, 2014) 
 _______________ 
 
 OPINION OF THE COURT 
 _______________ 
 
JORDAN, Circuit Judge. 
Tonya Marler appeals an order of the United States District Court for the Eastern 
District of Pennsylvania denying her recovery under the terms of the Diet Drug 
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Nationwide Class Action Settlement Agreement (“Settlement Agreement”).1  We will 
affirm. 
This appeal relates to the settlement of multi-district products liability litigation 
regarding the diet drugs Pondimin® and Redux®, previously sold by American Home 
Products (“AHP”).2  Marler’s claim for benefits based on moderate mitral regurgitation 
was first approved by an auditing cardiologist, then was rejected by the Settlement Trust 
based on evidence of intentional misrepresentation of her echocardiogram test, and, 
finally, was denied by the District Court for failure to demonstrate a reasonable medical 
basis for her condition.  She appeals,
3
 arguing that the evidence in the record met that 
                                              
1
 Marler is one of three claimants who have appealed simultaneously through the 
same counsel, the others being Ruth Sanders (Case No. 13-4548) and Elizabeth Lassetter 
(Case No. 13-4730).  All three relied on the same attesting physician in submitting their 
claims; they appeal the same issue – whether there was a reasonable medical basis to 
conclude they all suffered from moderate mitral regurgitation; and they raise the same 
arguments.  The briefs on appeal are almost identical, as are the District Court’s opinions 
regarding each claimant.  For efficiency’s sake, then, we designate our opinion regarding 
Ruth Sanders as primary and incorporate the background portion of that opinion herein.    
2
 In several prior decisions, we have provided a detailed description of the Diet 
Drugs litigation.  See, e.g., In re Briscoe, 448 F.3d 201, 206-08 (3d Cir. 2006); In re Diet 
Drugs Prods. Liab. Litig., 401 F.3d 143, 147-48 (3d Cir. 2005); In re Diet Drugs Prods. 
Liab. Litig., 385 F.3d 386, 389-92 (3d Cir. 2004); In re Diet Drugs Prods. Liab. Litig., 
282 F.3d 220, 225-29 (3d Cir. 2002).  We will therefore limit our discussion to the 
essential facts of the instant appeal.  
3
 The District Court had original jurisdiction over all terms of the Settlement 
Agreement under 28 U.S.C. §§ 1332 and 1407.  We exercise jurisdiction over a final 
order of the District Court pursuant to 28 U.S.C. § 1291.  As discussed in In re Diet 
Drugs Products Liability Litigation (Sanders), we review for an abuse of discretion the 
District Court’s exercise of its authority to administer and implement a class action 
settlement.  No. 13-4548, at 6 n.5. 
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burden of proof and that the Court erred by deputizing the Technical Advisor with 
judicial power.
4
   
Regarding both of Marler’s arguments, we find that she has failed to show any 
abuse of discretion in the District Court’s interpretation or factual findings.  The Court 
undertook a thorough review of the record, including both parties’ statements and the 
opinions of both auditing cardiologists, the Technical Advisor, and Marler’s own 
attesting physician.  The District Court’s reliance on the Technical Advisor was also 
within the limitations set by the Settlement Agreement.   
III.   Conclusion 
 For the foregoing reasons, we will affirm.  
                                              
4
 Marler also brings other meritless arguments that we briefly address and reject in 
Sanders, No. 13-4548, at *6 n.6. 
 
